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Abstract 
The macrophage mannose receptor (MR) is a pattern recognition receptor of the innate 
immune  system  that  binds  to  microbial  structures  bearing  mannose,  fucose  and 
N-acetylglucosamine on their surface. Trypanosoma cruzi antigen cruzipain (Cz) is found in the 
different developmental forms of the parasite. This glycoprotein has a highly mannosylated 
C-terminal  domain  that  participates  in  the  host-antigen  contact.  Our  group  previously 
demonstrated that Cz-macrophage (Mo) interaction could modulate the immune response 
against T. cruzi through the induction of a preferential metabolic pathway. In this work, we 
have studied in Mo the role of MR in arginase induction and in T. cruzi survival using different 
MR  ligands.  We  have  showed  that  pre-incubation  of  T.  cruzi  infected  cells  with  man-
nose-Bovine Serum Albumin (Man-BSA, MR specific ligand) biased nitric oxide (NO)/urea 
balance towards urea production and increased intracellular amastigotes growth. The study of 
intracellular signals showed that pre-incubation with Man-BSA in T. cruzi J774 infected cells 
induced down-regulation of JNK and p44/p42 phosphorylation and increased of p38 MAPK 
phosphorylation.  These results  are coincident  with  previous  data  showing  that  Cz  also 
modifies the MAPK phosphorylation profile induced by the parasite. In addition, we have 
showed by confocal microscopy that Cz and Man-BSA enhance MR recycling. Furthermore, 
we studied MR behavior during T. cruzi infection in vivo. MR was up-regulated in F4/80+ cells 
from T. cruzi infected mice at 13 and 15 days post infection. Besides, we investigated the effect 
of MR blocking antibody in T. cruzi infected peritoneal Mo. Arginase activity and parasite 
growth were decreased in infected cells pre-incubated with anti-MR antibody as compared 
with infected cells treated with control antibody. Therefore, we postulate that during T. cruzi 
infection, Cz may contact with MR, increasing MR recycling which leads to arginase activity 
up-regulation and intracellular parasite growth. 
Key words: T. cruzi, macrophage, arginase, iNOS, mannose receptor. 
Introduction 
Trypanosoma cruzi, an obligate intracellular pro-
tozoan  parasite,  is  the  etiological  agent  of  human 
Chagas disease, a widely distributed debilitating in-
fection, which constitutes a major health problem in 
Latin American countries. This parasite infects a wide 
range of host cell types including Mo [1]. The ability 
of T. cruzi to infect and replicate within a variety of 
cell types is an essential feature of its cycle.  
Mo are important effector cells involved in var-
ious phases of immune responses, such as phagocy-
tosis, antigen presentation, and secretion of bioactive 
molecules [2, 3]. Mo may either inhibit T. cruzi repli-
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cation or provide a favorable environment in which it 
can multiply and be disseminated to other sites within 
the  body  [1].  However,  pathogens  have  developed 
several  strategies  to  circumvent  microbicidal  re-
sponses  of  host  cells.  It  has  been  postulated  that 
phagocytosis through receptors that bypass the bac-
tericidal activity of Mo may provide an opportunity 
for pathogens to manipulate the host environment to 
their own advantage [4, 5].  
Mo  exposure  to  Th1  cytokines  or  bacterial 
products such as LPS or CpG DNA, induces classical 
activated Mo that produce NO. This provides a key 
defensive  element  in  various  infectious  diseases.  In 
contrast, Mo differentiated in the presence of Th2 cy-
tokines have enhanced capacity for endocytosis but 
do not exert enhanced killing functions towards mi-
crobes  [6,  7].  Furthermore,  NO  production  is  coun-
teracted by the expression of arginase, an enzyme that 
competes with inducible nitric oxide synthase (iNOS) 
for  L-arginine  that  leads  to  L-ornithine  and  urea 
production [8].  
Cruzipain (Cz), one of the immunodominant an-
tigens of T. cruzi, is a glycoprotein of about 52-58 kDa 
that  has  both  high  mannose-  and  com-
plex-type-N-linked glycans at the C-terminal domain 
[9-12].  It  is  found  in  every  developmental  form  of 
parasites [13] and it has been reported to be highly 
immunogenic in human infection [12, 14]. Moreover, 
it has been shown that mice-immunization with Cz 
elicits humoral and cellular immune responses  [15]. 
Given that the activation of arginase may be an effec-
tive mechanism for regulating NO production in Mo, 
we previously investigated the influence of L-arginine 
catabolism on T. cruzi growth through the interaction 
of Mo with Cz [16-18]. We showed that Cz induced 
alternative activation of Mo in vitro and up-regulated 
arginase activity. This Mo activation profile was as-
sociated with the functional ability  of these cells to 
promote the intracellular  growth of  T. cruzi [16]. In 
addition,  we  previously  demonstrated  that  Cz  in-
duced  arginase  through  the  activation  of  multiple 
signaling pathways including Tyrosine Kinase (TK), 
Protein Kinase A (PKA) and p38 MAPK [17, 18].  
On  the  other  hand,  protein  expression  studies 
and  transcriptional  profiling  have  shown  that  IL-4 
induces  up-regulation  of  the  MR  and  other  several 
receptors on monocytes and Mo [19-23], while MR is 
down-regulated in classically activated Mo [24]. MR is 
a multi-domain protein composed of a cysteine-rich 
domain  with  lectin  activity  that  binds  to  sulphated 
sugars, a fibronectin type-II (FNII) domain that me-
diates  binding  to  collagen  [25]  and  eight 
C-type-lectin-like  domains  (or  carbohy-
drate-recognition  domains,  CRD).  The  fourth  CRD 
mediates most of the specificity of these domains for 
glycans terminating in mannose, fucose and N-acetyl 
glucosamine.  In  addition  to  many  endogenous  lig-
ands, MR binds to bacteria (e.g. Mycobacterium tuber-
culosis),  fungi  (e.g.  Pneumocystis carinii)  and  viruses 
(e.g.  HIV).  MR  is  expressed  on  the  surface  of  Mo, 
dendritic cells (DC) and some epithelial cells. In addi-
tion, it is constitutively internalized from the plasma 
membrane by clathrin-mediated endocytosis and re-
cycled back to the cell surface  [26]. Receptor-ligand 
dissociation  occurs  under  the  influence  of  low  pH 
within endosomal membrane vesicles. A proportion 
of internalized receptor-ligand complexes fail to dis-
sociate,  and  are  returned  to  the  cell  surface  intact, 
suggesting  the  presence  of  alternative  endocytosis 
pathways [27, 28]. Intracellular targeting is mediated 
by a tyrosine-based motif in the cytoplasmic tail, alt-
hough it contains no recognized signalling motifs [29]. 
MR-pathogen interactions have been implicated in the 
initiation  of  signaling  pathways  leading  to  the  pro-
duction of lysosomal enzymes  [30], reactive oxygen 
and  nitrogen  molecules  [31,  32]  and  IL-1,  IL-6, 
GM-CSF [33], TNFα [34] and IL-12 [35]. In addition, 
MR has also been implicated in the delivery of anti-
gens to intracellular compartments containing MHC 
class  II  molecules  participating  in  foreign  antigens 
presentation [36].  
Given  that,  MR  has  been  implicated  in  the 
recognition of several pathogens by Mo [19] and it has 
been associated with Mo alternative activation, in this 
work we studied the role of MR in arginase induction 
and  T. cruzi survival in Mo using different MR lig-
ands. 
 
Materials and Methods 
Parasites and infection protocols 
T. cruzi epimastigote forms from Tulahuen strain 
were grown at 28 ⁰C in brain heart infusion supple-
mented with 0.5% tryptose (Becton Dickinson), 10% 
FCS, 200 mg/ml hemin, 100 U/ml penicillin, and 100 
mg/ml streptomycin. Parasites were harvested at the 
exponential growth phase, then centrifuged at 5000×g 
for 10 min at 4 ⁰C, and washed with PBS.  
T. cruzi trypomastigote  (Tp)  forms  were  main-
tained by serial passage in BALB/c mice (Comisión 
Nacional de Energía Atómica, Buenos Aires, Argen-
tina). Male BALB/c mice, 6–8 weeks old, were intra-
peritoneally  infected  with  500  T. cruzi Tp  forms  di-
luted in PBS. The studies are approved by the Institu-
tional  Review  Board  and  Ethical  Committee  of  the 
School of Chemical Sciences, National University of 
Córdoba, Argentina. Int. J. Biol. Sci. 2011, 7 
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Antigen 
Cruzipain  purification:  T.  cruzi  epimastigote 
forms from Tulahuen strain were grown at 28 ⁰C in 
brain heart infusion (Becton Dickinson, France) sup-
plemented with 0.5% tryptose, 10% FCS, 200 mg/ml 
hemin, 100 U/ml penicillin, and 100 mg/ml strepto-
mycin.  Parasites  were  harvested  at  the  exponential 
growth phase, centrifuged at 5000×g for 10min at 4⁰C, 
and washed with PBS. Parasites were resuspended in 
3 vol of 0.25 M sucrose, 5 mM KCl and the following 
irreversible  protease  inhibitors:  1  mM  TLCK  and  1 
mM PMSF (Sigma Chemical Co., St. Louis, MO, USA). 
The epimastigotes were disrupted by three cycles of 
freezing (-20 ◦C) and thawing (4 ◦C), and the homog-
enates were centrifuged at 7000×g for 15 min at 4 ◦C. 
Saturated ammonium sulfate solution, adjusted to pH 
7 with NH4OH, was added at 50% saturation to the 
supernatant, with stirring in an ice bath [10]. The pre-
cipitate obtained after centrifugation of this suspen-
sion was carefully dissolved and dialyzed in a solu-
tion  with  50  mM  Tris–HCl,  150  mM  NaCl,  pH  7.4. 
CaCl2, MgCl2 and MnCl2 were added to the dialyzed 
solution to provide a final concentration of 5mM for 
each salt. Subsequently, the samples were submitted 
to  affinity  chromatography  as  previously  described 
[37]. The absence of enzyme activity was checked by 
10% SDS-PAGE containing 0.1% gelatin as substrate. 
After the electrophoresis performed at 120V, the gel 
was incubated with 50mM sodium phosphate buffer 
pH  5.7  at  37  ◦C  overnight,  and  stained  with  Coo-
massie Brilliant Blue R250. The samples were neither 
reduced  nor  boiled  [38].  Lipopolyssacharide  (LPS) 
contamination of this preparation was ruled out using 
the Limulus assay (BioWhittaker). 
Cell cultures 
The  murine  Mo  cell  line  J774  was  cultured  in 
RPMI 1640 containing 10% fetal bovine serum (FBS), 
4mM glutamine and 40 μg/ml gentamycin at 37 ⁰C in 
5% CO2. 
Resident peritoneal cells culture 
Normal  resident  peritoneal  cells  from  BALB/c 
mice  were  obtained  by  several  peritoneal  washings 
with complete RPMI medium. 
Cells treatment 
J774 or peritoneal cells were incubated with in-
creasing  concentrations  of  mannan  from  Saccharo-
myces  cerevisiae  (Sigma-Aldrich,  Saint  Louis  MO, 
USA),  α-mannopyranoside  (Sigma-Aldrich),  man-
nose-BSA (Sigma-Aldrich) or EDTA (Sigma-Aldrich) 
for 2 h. Then cells  were infected by exposure to T. 
cruzi  Tp  forms  for  24  h.  Cells  were  subsequently 
washed for removing the non-internalized parasites.  
Determination of arginase activity 
J774  cells  (1x106/ml)  or  peritoneal  cells 
(1x106/ml)  were  treated  as  previously  described 
above. Arginase activity was measured in cell lysates 
as  described  previously  [16,  39].  Briefly,  cells  were 
lysed with 50 µl of 0.1% Triton X-100 containing pro-
tease inhibitors. This mixture was stirred for 30 min 
and then 50 μl of 10 mM MnCl2 with 50 mM Tris-HCl 
we added to activate the enzyme for 10 min at 56 ◦C. 
Arginine hydrolysis was initiated by the addition of 
25 µl of 0.5 M L-arginine, pH 9.7, at 37 ◦C for 45 min. 
The reaction was stopped with a mixture of acids, and 
the urea concentration was measured at 540 nm after 
the  addition  of  25  μl  of  α-isonitrosopropiophenone 
(dissolved in 100% ethanol) followed by heating at 95 
◦C for 45 min. The results are expressed as Arginase 
Index  (fold  increase  of  arginase  activity  in  samples 
above basal). 
NO assay 
J774 cells (1×106 cells/well) were treated as pre-
viously described above. Supernatants were collected 
at 48 h and mixed with an equal volume of  Griess 
reagent [40]. Optical density measurements were av-
eraged  and  converted  to  micromoles  of  nitrites  per 
well using a standard curve of sodium nitrite. Results 
are expressed as Nitrites Index (fold increase of ni-
trites in samples above basal). 
Trypanocidal activity 
J774 cells (2×105/ml) were treated as previously 
described above and infected with T. cruzi Tp at three 
parasites per cell ratio and were cultured for 48 hr at 
37 oC in a humidified 5% CO2 atmosphere. After 24 hr, 
cells were washed to remove extracellular parasites. 
The number of parasites was determined by indirect 
immunofluorescence [16]. The slides were taken 72 h 
later; washed three times with PBS and fixed in 4% 
formol–PBS for 45 min. Then, they were treated with 
1% Triton X-100 for 15 min. After washing with PBS, 
the slides were blocked with 1% PBS–BSA for 15 min. 
Subsequently, the slides were incubated overnight at 
4  oC with positive Chagas serum diluted with PBS. 
Slides  were  washed  and  FITC-labelled  anti-human 
IgG was added in 1% PBS–BSA. After 1 hr, slides were 
washed three times with PBS and were mounted on 
PBS-Glycerin.  The  results  are  expressed  as 
Amastigotes  number  Index  (fold  increase  of 
amastigotes  number  in  samples  above  that  of 
non-treated infected cells). Int. J. Biol. Sci. 2011, 7 
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Western blot analysis 
J774 cells (1×106) were pretreated with Man-BSA 
or mannan for 2 h and then incubated with the para-
site for during 30 min. Following these treatments the 
cells were lysed and Western blot analysis was per-
formed  as  previously  described  [16].  Membranes 
were  probed  by  using  the  rabbit  antibody  an-
ti-phospho p38, anti-phospho p44/p42, anti-phospho 
JNK  at  1:1000  dilution  (Cell  Signaling  Technology, 
Beverly, MA, USA) and β-actin at 1:1000 dilution (Cell 
Signaling  Technology)  followed  by  anti-rabbit  pe-
roxidase  conjugated  (Sigma-Aldrich)  at  1:1000  dilu-
tion.  Bands  were  visualized  using  a  chemilumines-
cence reaction (Amersham Biosciences, UK). 
Flow cytometry 
MR  recycling:  J774  or  peritoneal  cells 
(1x106cells/well) were incubated for 15, 30, 60, 90, 120, 
150  and  180  min  with  FITC-Man-BSA  (500  ng/ml) 
(Sigma-Aldrich) or IL-13 (BD Biosciences) for 180 min 
at  room  temperature.  Then,  cells  were  washed  for 
removing  not  bound  FITC-Man-BSA  and  fixed.  On 
the  other  hand,  J774  cells  (1x106cells/well)  were 
treated with Cz (25, 50 or 75 ug/ml) during 2 h and 
then incubated with FITC-Man-BSA (500 ng/ml) for 
20 min. Then cells were washed to remove unbound 
FITC-Man-BSA and fixed. FITC+ cells were analyzed 
by flow cytometry (FACS Canto II, BD Biosciences, 
San  Jose,  CA).  Results  were  analyzed  using 
FACS-DIVA software (BD Biosciences). 
Ex vivo studies: Peritoneal cells from T. cruzi in-
fected BALB/c mice were removed at 13 and 15 days 
post  infection.  In  addition  peritoneal  cells  from 
non-infected BALB/c mice were used as control. Cells 
were  incubated  with  FITC-labeled  Man-BSA  and 
PE-labeled  anti-mouse  F4/80  antibody  (BD  Biosci-
ences,  Pharmingen,  San  Diego,  CA).  After  20  min, 
cells were washed to remove unbound FITC-labeled 
Man-BSA  and  PE-labeled  anti-F4/80  antibodies. 
FITC+ PE+ cells were analyzed by flow cytometry. 
Interaction Cz-MR: Peritoneal cells from BALB/c 
mice were incubated for 30 min with Cz (50 ug/ml), 
Man-BSA  (750  ng/ml)  or  BSA  (750  ng/ml)  (Sig-
ma-Aldrich). Peritoneal cells were washed and fixed. 
Then,  cells  were  incubated  for  30  min  with 
FITC-labeled anti-MR antibody (10 ug/ml, Santa Cruz 
Biotechnology,  Santa  Cruz,  CA).  FITC+  cells  were 
analyzed by flow cytometry.  
Acidic  solution  treatment:  J774  cells  were  incu-
bated for 3 h with FITC-Man-BSA at room tempera-
ture. After incubation, cells were washed with regular 
buffer or with acidic solution (Glycin-HCl pH:2,7) to 
remove FITC-Man-BSA on the cell surface. 
Confocal Microscopy  
J774 cells on glass coverslips were incubated for 
1,  2  or  3  h  with  FITC-Man-BSA  (500  ng/ml)  or 
FITC-Cz  (50  ug/ml)  at  4  oC  or  room  temperature. 
Then, cells were treated with regular buffer or with 
acidic solution and they  were analyzed by confocal 
microscopy (FV-300, Olympus, Miami, FL).  
Statistical analysis 
The Mann-Whitney U-test was used to compare 
the  data  corresponding  to  treated  and  non-treated 
groups. A p-value <0.05 was considered as statistically 
significant. 
Results 
Man-BSA modifies iNOS/arginase balance fa-
voring Trypanosoma cruzi survival in macro-
phages. 
We  have  previously  demonstrated  that  the  in-
teraction  between  Cz  and  Mo  could  modulate  the 
immune response against T. cruzi through the induc-
tion  of  a  preferential  metabolic  pathway  in  Mo.  To 
investigate whether MR is involved in arginine me-
tabolism in  T. cruzi-infected Mo, J774 cells were in-
cubated  with  increasing  concentrations  of  different 
MR-ligands such as mannan from Saccharomyces cere-
visiae  (mannan),  α-mannopyranoside  (αMM), 
Man-BSA or EDTA (Ca++ sequester) for 2 h. Subse-
quently, cells were infected by exposure to T. cruzi Tp 
forms for 24 h and afterward they were washed to 
remove the non-internalized parasites. After 48 h urea 
or nitrite concentrations were measured in cell lysates 
or in culture supernatants, respectively. 
Man-BSA  pre-incubated  Mo  showed  a  higher 
level  of  urea  than  control  cells.  In  contrast,  EDTA 
pre-incubated Mo showed lower urea levels as com-
pared with control cells (Fig. 1A). In addition, mannan 
or αMM pre-incubated Mo did not show changes in 
urea levels as compared with control cells. Besides, 
we  did  not  observed  changes  in  urea  levels  in 
MR-ligand  pre-treated  and  in  non-infected  cells. 
Moreover, we obtained similar results using perito-
neal cells (data not shown). Furthermore, these results 
were  consistent  with  iNOS  activity.  Man-BSA  pre-
treated Mo showed lower nitrites levels than control 
cells. In contrast, mannan and αMM pretreated cells 
did  not  show  differences  in  nitrites  production  as 
compared with control cells (Fig. 1B).  
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Figure  1. Man-BSA  modifies  the  balance  NO/arginase  favoring  the  survival  of  T. cruzi  in  Mo. J774 cells 
(1x10
6cells/well) were plated and incubated for 2 h with increased concentrations of mannan of Saccharomyces cerevisiae 
(mannan) (2.5, 5, 10 mg/ml), α-mannopyranoside (αMM) (50, 100, 200 mM), mannose-BSA (Man-BSA) (250, 500, 750 ng/ml) 
or EDTA (0.5, 1, 2 mM). Then, cells were infected with T. cruzi Tp forms (three parasites per cell). After 18 h, cells were 
washed to remove the non-internalized parasites. After 48 h, arginase activity was evaluated measuring urea levels in 
macrophage lysates (A) and iNOS activity was also examined by measuring nitrites levels in culture supernatants (B); infected 
(grey bars) and non infected cells (white bars). Peritoneal cells (2x10
5cells/well) were plated on 12-mm round-glass co-
verslips and were treated in the same form described above. The number of amastigotes/100 cells was counted after 72 h 
using a fluorescence microscope (C). Data represent mean of triplicates ﾱ SD of three independent experiments. (*p≤0.05, 
** ≤ 0.01, *** ≤0.001). Int. J. Biol. Sci. 2011, 7 
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Mannan pre-treatment without T. cruzi infection 
may increase nitrites concentrations because this pol-
ysaccharide also interacts  with Toll-Like Receptor 4 
(TLR4) [41]. Therefore, Man-BSA pre-treatment in T. 
cruzi infected cells was able to induce arginase activity 
and to reduce NO production in culture supernatants.  
It has been reported that arginase induction has 
a detrimental role during several parasite infections 
by limiting classically activated Mo-dependent clear-
ance and promoting parasite proliferation [6, 7, 42]. 
We  have  previously  reported  that  Cz  promotes  T. 
cruzi intracellular growth in a similar way to IL–4 [16]. 
To investigate the role of arginase in parasite growth 
induced by Man-BSA, peritoneal cells were incubated 
with  increased  concentrations  of  mannan,  αMM, 
Man-BSA or EDTA for 2 h. After that, cells were in-
fected by exposure to T. cruzi Tp for 24 h and then 
washed, fixed and stained. Intracellular amastigotes 
were counted at 72 h by immunofluorescence assays 
[17]. We only observed an increase in parasite number 
in  Man-BSA-pre-treated  Mo  compared  to  untreated 
cells (Fig. 1C). Therefore, Man-BSA induced a shift in 
L-arginine metabolism that promotes parasite growth. 
Man-BSA inhibits JNK and p44/p42 MAPK ac-
tivation induced by T. cruzi.  
We  have  previously  demonstrated  that  Cz  in-
duced  activation  of  p38  MAPK,  while  the  parasite 
produced JNK and p44/p42 phosphorylation. More-
over, MAPK phosphorylation changed and JNK acti-
vation  was  blocked  when  Mo  were  pre-incubated 
with Cz, before coming into contact with T. cruzi [17, 
18].  
In  the  present  work,  we  evaluate  whether 
Man-BSA pre-treatment was able to modified MAPK 
phosphorylation pattern induced by the parasite. To 
test that, peritoneal cells were incubated for 2 h in the 
presence of increasing concentrations of Man-BSA or 
mannan, and then infected with T. cruzi Tp. Man-BSA 
pre-treatment at the highest concentration markedly 
reduced  p44/p42  phosphorylation  compared  to 
non-treated  infected  cells  (Fig.  2A).  In  addition, 
Man-BSA  pre-treatment  blocked  JNK  phosphoryla-
tion induced by the parasite (Fig. 2B). On the other 
hand,  Man-BSA  treatment  at  the  highest  concentra-
tion, increased p38 MAPK phosphorylation induced 
by  the  parasite  (Fig.  2C).  Therefore,  similar  to  Cz, 
Man-BSA is able to change MAPK phosphorylation 
profile induced by the parasite [17,18].  
 
Figure  2.  Man-BSA  inhibits  JNK  and  p44/p42  MAPK  activation  induced  by  T.  cruzi.  Peritoneal  cells 
(2x10
6cells/well) were cultured with Man-BSA (250, 500 and 750 ng/ml), mannan (2.5, 5 or 10 ug/ml) or medium (-) for 2 h 
and then infected with Tp of T. cruzi (three parasite per cell) for 30 min. Whole-cell lysates were resolved by SDS-PAGE 
(10%), followed by Western blot using antibodies against phospho-JNK, phospho-p38, phospho-p44/p42 or β-actin. Peri-
toneal cells treated with FBS (20%, 30 min) were used as control for p44/p42 phosphorylation (A), UV-treated cells were 
used as control for JNK phosphorylation (B) and NaCl-treated cells (300mM, 30min) were used as control for p38 MAPK 
phosphorylation (C) Int. J. Biol. Sci. 2011, 7 
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Role of MR in Man-BSA-Mo and Cz-Mo inter-
actions. 
We  have  showed  that  iNOS/arginase  balance 
was  biased  towards  arginase  in  Man-BSA 
pre-incubated T. cruzi infected Mo (Fig. 1A and 1B). 
Moreover, intracellular parasite growth was increased 
(Fig. 1C). In addition, the study of MAPK intracellular 
signals  showed  that  pre-incubation  with  Man-BSA 
induced p-JNK and p-p44/p42 down-regulation and 
p-p38 MAPK up-regulation in T. cruzi infected J774 
cells (Fig. 2). These results are coincident with previ-
ous data published by our group [17,18] and suggest 
that Man-BSA and Cz might interact with the same 
receptor.  Moreover,  Man-BSA  pre-incubation  may 
stimulate  intracellular  signals  to  induce  MR 
up-regulation or to increase MR recycling on Mo sur-
face. To test this hypothesis we study by flow cytom-
etry MR expression in Man-BSA or Cz treated cells. 
Peritoneal cells were incubated with FITC-Man-BSA 
at different time points and then they were washed to 
remove unbound FITC-Man-BSA. IL-13 was used as a 
positive  control  in  these  experiments  because  it  is 
known to up-regulate MR expression (Fig. 3A). Flow 
cytometry  analysis  showed  that  FITC-Man-BSA  in-
cubation increased the percentage of FITC+ cells over 
the time. We obtained similar results using J774 cells 
(data not shown). To determine whether the increase 
in the percentage of FITC+ cells observed in Fig. 3A 
depends  on  the  mannosylated  portion,  J774  cells 
where incubated with BSA or Man-BSA, for 2 h and 
then incubated with FITC-Man-BSA for 20 minutes. 
After  that,  cells  were  washed  to  remove  unbound 
FITC-Man-BSA and they were analyzed by flow cy-
tometry.  We  observed  that  Man-BSA  but  not  BSA 
pre-incubation  increased  the  percentage  of  FITC+ 
cells  after  FITC-Man-BSA  incubation  (Fig.  3B),  con-
firming that the mannosylated fraction might deter-
mine an increase in MR expression or MR recycling. 
Subsequently, to evaluate whether Cz has a same ef-
fect on MR behavior, J774 cells were incubated with 
increasing concentrations of Cz during 2 h and then 
they  were  incubated  with  FITC-Man-BSA  for  20 
minutes.  Flow  cytometry  analysis  showed  that  Cz 
pre-treatment increased the percentage of FITC+ cells 
in  a  dose-dependent  manner  when  compared  with 
control cells (basal) (Fig. 3C). In addition, J774 cells 
incubated with increasing concentrations of mannan 
or  BSA  during  2  h  and  then  incubated  with 
FITC-Man-BSA for 20 min, did not show difference in 
the percentage of FITC+ cells as compared to control 
cells (data not shown). In contrast, J774 cells incubated 
with  increasing  concentrations  of  Man-BSA  aug-
mented  the  percentage  of  FITC+  cells  (data  not 
shown). Therefore, this experiment may indicate that 
Cz and Man-BSA may induce an increase in MR ex-
pression or MR recycling.  
Man-BSA-Mo and Cz-Mo interactions in-
creased MR recycling. 
Next,  we  studied  whether  Cz  or  Man-BSA  in-
duced MR up-regulation or increased MR recycling. 
To test that, J774 cells were incubated for 3  h with 
FITC-Man-BSA at room temperature. After that, cells 
were washed with regular buffer or with acidic solu-
tion to remove FITC-Man-BSA from cell surface and 
then cells were fixed and analyzed by flow cytometry 
(Fig.  4A).  We  observed  that  acidic  solution  did  not 
modify  the  percentage  of  FITC+  cells  as  compared 
with cells washed with regular buffer. This may in-
dicate  that  FITC-Man-BSA  could  be  endocyted.  In 
addition,  J774  cells  were  incubated  with 
FITC-Man-BSA (Fig. 4B) or FITC-Cz (Fig. 4C) for 15, 
60, 120 or 180 min at room temperature or 180 min at 4 
oC.  Then,  cells  were  treated  with  regular  buffer  or 
with acidic solution and they were analyzed by con-
focal  microscopy.  This  study  showed  that 
FITC-Man-BSA up-take increased over the time and it 
was not affected by acidic wash (Fig. 4B). In addition, 
FITC-Cz  also  increased  inside  cells;  however  it  is 
slightly affected by acidic solution (Fig. 4C). On the 
other  hand,  incubation  at  low  temperature  blocked 
FITC-Man-BSA  or  FITC-Cz  internalization  (Fig.  4B 
and  4C).  Consequently,  we  have  showed  that  MR 
expression on Mo may be constitutive with no signif-
icant changes upon its ligands contact. However, our 
results suggest that after Man-BSA or Cz contact, MR 
efficiently recycles on the cell surface.  
 
Cz-MR interaction on macrophages. 
To  determine  whether  Cz  could  interact  with 
MR,  we  examined  the  ability  of  Cz  to  reduce 
FITC-anti-MR binding on Mo. To test that, peritoneal 
cells were incubated with Cz, Man-BSA, BSA or me-
dium  (negative)  for  30  min  and  then  cells  were 
washed  and  fixed.  After  that,  cells  were  incubated 
with FITC-labeled anti-MR antibody for 30 min and 
analyzed by flow cytometry (Fig. 5). We observed that 
Cz or Man-BSA pre-incubation reduce FITC-anti-MR 
specific binding to MR. In contrast, no changes were 
observed when cells were incubated with BSA as a 
control. Consequently, this may indicate a direct in-
teraction of Cz with MR on peritoneal Mo surface.  Int. J. Biol. Sci. 2011, 7 
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Figure 3. Role of MR in the interaction between Man-BSA and Cz with Mo. Peritoneal cells (1x10
6cells/well) were 
incubated for 15, 30, 60, 90, 120, 150 and 180 min with FITC-Man-BSA (500ng/ml) or IL-13 for 180 min at room temper-
ature. Then, cells were washed for removing unbound FITC-Man-BSA and fixed (A). J774 cells (1x10
6cells/well) were treated 
with Man-BSA (750ng/ml), BSA (750ng/ml), FITC-Man-BSA (750ng/ml) or left it untreated (basal) during 2 h. Then, cells 
treated with Man-BSA, BSA and basal cells were incubated with FITC-Man-BSA (500ng/ml) for 20 minutes. After that, cells 
were washed to remove unbound FITC-Man-BSA and fixed (B). J774 cells (1x10
6cells/well) were treated with Cz (25, 50 or 
75ug/ml) during 2 h or left it untreated (basal) and then incubated with FITC-Man-BSA (500ng/ml) for 20 minutes. Then, cells 
were washed to remove unbound FITC-Man-BSA and fixed (C). FITC+ cells were analyzed by flow cytometry. Bars rep-
resent the mean ± SD. Data are representative of three independent experiments. Int. J. Biol. Sci. 2011, 7 
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Figure 4. Increased MR recycling induced by Man-BSA and Cz contact with Mo. J774 cells (1x106cells/well) 
were incubated with FITC-Man-BSA (500ng/ml) for 20 min (basal) or 3 h. After incubation, cells were washed with regular 
buffer or with acidic solution and they were analyzed by flow cytometry. Bars represent the mean ± SD. Data are repre-
sentative of three independent experiments (A). J774 cells (1x10
6cell/well) were incubated for 15, 60, 120 and 180 min with 
FITC-Man-BSA (500ng/ml) (B) or FITC-Cz (50ug/ml) (C) at room temperature (RT) or 4
oC (180 min). Then, cells were 
washed with regular buffer or with acidic solution and they were analyzed by confocal microscopy. Cells were observed at 
a 40x magnification. A representative field for each group is shown. Magnified image of the cells is shown in right box.
 
Figure 5. Cz-MR interaction on Mo. Peritoneal cells from BALB/c mice were incubated for 30 min with Cz (50ug/ml), 
Man-BSA (750 ng/ml), BSA (750ng/ml) or medium (-). Then, cells were washed, fixed and incubated for 30 min with 
FITC-labeled anti-MR antibody (10ug/ml). FITC+ cells were analyzed by flow cytometry. The bars represent the mean ± SD. 
Data are representative of three independent experiments. Int. J. Biol. Sci. 2011, 7 
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MR expression in F4/80+ cells from T. cruzi in-
fected mice.  
We  have  indirectly  determined,  through 
Man-BSA interaction, that MR plays an important role 
in arginase induction and in parasite growth in vitro. 
In addition, we have showed that arginase expression 
and activity is up-regulated in Mo from infected mice 
at  15-19  days  post  infection  (d.p.i)  (Stempin  et  al. 
unpublished  data)  and  these  results  are  coincident 
with parasitemia peak [43]. Therefore, we evaluated if 
MR  was  up  regulated  on  Mo  of  T.  cruzi  infected 
BALB/c  mice.  To  test  that,  peritoneal  cells  from  T. 
cruzi infected BALB/c mice were removed at 13 and 
15  d.p.i.  Peritoneal  cells  were  incubated  with 
FITC-Man-BSA  and  PE-labeled  anti-mouse  F4/80 
antibody.  After  20  min,  cells  were  washed  and  the 
number of F4/80+ MR+ double positive cells was an-
alyzed by flow cytometry. As Fig. 6 shows, we ob-
served an increase in F4/80+ MR+ double positive cells 
along  as  the  infection  progress  as  compared  with 
control non-infected cells. Therefore, MR may play an 
important role in vivo during T. cruzi infection.  
 
 
Figure 6. MR expression in F4/80+ cells from T. cruzi infected mice. Peritoneal cells from T. cruzi infected mice 
were removed at 13 and 15 days post infection. Peritoneal cells were incubated with FITC-labeled Man-BSA and PE-labeled 
anti-mouse F4/80 antibody. After 20 min, cells were washed and the number of F4/80+ and Man-BSA+ cells were analyzed 
by flow cytometry. Peritoneal cells from non-infected mice (control) were incubated with FITC-labeled Man-BSA and 
PE-labeled anti-mouse F4/80 antibody for 20 min. Bars represent mean ± SD. Data are representative of three independent 
assays. 
 
MR blockade decreased arginase activity and 
parasite growth in T. cruzi-infected macro-
phages. 
We  have  demonstrated  that  Cz-Mo  and 
Man-BSA-Mo  interactions  could  influence  T.  cruzi 
growth through the induction of a preferential meta-
bolic pathway by modulating the intracellular signals 
that regulate L-arginine metabolism (Fig. 1 and 2). In 
addition, we saw an increase in F4/80+ MR+ double 
positive cells during T. cruzi infection (Fig. 6). There-
fore,  we  decided  to  investigate  MR  relevance  in  T. 
cruzi  infection  by  blocking  MR  in  peritoneal  cells 
cultures infected in vitro. To do that, peritoneal cells 
were incubated for 2 h with anti-MR or control IgG 
and then treated cells were infected with T. cruzi Tp 
(three parasites per cell). After 24 h, cells were washed 
to remove non-internalized parasites. Arginase activ-
ity  was  measured  (Fig.  7A)  and  intracellular 
amastigote number was determined by immunofluo-
rescence [18] 72 h later (Fig. 7B). We observed a re-
duction  in  arginase  activity  in  anti-MR  antibody 
pre-incubated infected cells as compared with control 
cells (Fig. 7A). Moreover, the amastigote number was 
reduced in anti-MR pre-treated cells (Fig. 7B and 7C). 
These data were corroborated using J774 cells (data 
not  shown).  Therefore,  MR  may  facilitate  T.  cruzi 
growth within Mo through the induction of arginase 
activity.  
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Figure 7. MR blockade in in vitro T. cruzi-infected macrophages decreased arginase activity and parasite 
growth. Peritoneal cells (5x10
5cells/well) were incubated for 2 h with anti-MR IgG or control IgG. Treated cells were then 
infected with T. cruzi Tp (three parasites per cell). After 24 h, cells were washed to remove non-internalized parasites and 72 
h later arginase activity was determined in cells lysates (A). Peritoneal cells (5x10
5 cells/well) were plated on 12-mm 
round-glass coverslips and incubated for 2 h with anti-MR IgG or control IgG. Treated cells were infected with T. cruzi Tp 
(three  parasites  per  cell).  After  24  h,  cells  were  washed  to  remove  non-internalized  parasites  and  the  number  of 
amastigotes/100 cells was counted 72 h later by immunofluorescence. Bars represent mean of triplicates ± SD of three 
independent experiments (B). Cells were observed at 100x, 40x and 20x magnification. A representative field for each group 
is shown (C). Int. J. Biol. Sci. 2011, 7 
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Discussion 
Mo activation by T helper type 1 (Th1) cytokines 
or  bacterial  products  such  as  lipopolysaccharide  or 
CpG DNA, induces NO production that provides a 
key defensive element in various infectious diseases. 
On the other hand, Mo differentiated in the presence 
of Th2 cytokines have enhanced capacity for endocy-
tosis but do not exert enhanced killing functions to-
wards microbes [6, 7, 44]. Furthermore, NO produc-
tion is counteracted by the expression of arginase-1, 
an enzyme that competes with iNOS for L-arginine, 
leading to the production of L-ornithine and urea [8, 
45,  46].  We  have  previously  demonstrated  that  Cz 
induced  alternatively  activated  Mo  [16,  47]. 
Cz-stimulated Mo exhibit increased arginase-1 activ-
ity and expression, and secrete IL-10 and TGF-β [16, 
17]. Moreover, Cz-activated Mo favors T. cruzi growth 
[16]  and  arginase-1  inhibition  leads  to  a  drastic  re-
duction in T. cruzi replication in Mo [18]. In addition, 
we showed that mice immunization with the immune 
dominant  antigen  Cz  results  in  high  Th2  cytokine 
secretion (IL- 4, IL-5, IL-10), and marginal levels of 
IFN-γ and IL-12 [47].  
One of the hallmarks of alternatively activated 
Mo is the increased expression of the MR [6, 23]. This 
receptor is a C-type lectin primarily expressed on Mo 
and DC. Its three distinct extracellular binding sites 
recognize a wide range of both endogenous and ex-
ogenous ligands, therefore MR has been implicated in 
homeostatic processes and in pathogen recognition. In 
order to study possible receptors involved in arginase 
induction  we  perform  experiments  using  different 
MR  ligands.  Surprisingly,  our  results  demonstrated 
that  Man-BSA  pre-incubation,  but  not  mannan  or 
αMM,  modifies  iNOS/arginase  balance.  Moreover, 
this result is in accordance to Chieppa et al. [48]. The 
authors showed that not all MR ligands had the same 
functional effects on cells. While mannan had no sig-
nificant  effect  on  cytokine  production,  man-
nose-capped LAM (Man-LAM) significantly increased 
IL-10  and  decreased  IL-12  production  in 
LPS-maturing DC. In addition, Liempt et al. demon-
strated that schistosome soluble egg antigens (SEA) 
internalization  through  C-type  lectins  (DC-SIGN, 
MGL  and  MR)  on  DC,  induced  DC  activation  and 
subsequent production of cytokines contributing the 
Th1/Th2  balance  [49].  Our  results  suggest  that  the 
specific MR-ligand Man-BSA shifted iNOS/arginase 
balance  towards  arginase  promoting  T.  cruzi  intra-
cellular growth. Therefore, Man-BSA is able to induce 
on  Mo  a  similar  profile  to  the  one  observed  in 
Cz-treated  Mo  [16].  Then,  this  work  is  the  first  to 
identify a specific MR ligand able to trigger arginase 
activity. Our results also suggest that Cz may mediate 
its effect by the interaction with MR, since it is able to 
reduce anti-MR binding on Mo.  
On the other hand, parasites are not only able to 
successfully  reside  in  Mo,  but  are  also  capable  to 
modify signaling cascades from these cells in order to 
overcome different immune defense mechanisms. To 
explore  whether  different  signalling  pathways  are 
involved in iNOS/arginase balance bias we studied 
MAPK  activation.  We  observed  that  Man-BSA 
pre-treatment reduces p44/p42 MAPK phosphoryla-
tion and blocks JNK phosphorylation induced by T. 
cruzi.  In  contrast,  Man-BSA  pre-treatment  increased 
p38 MAPK phosphorylation induced by the parasite. 
Therefore, we demonstrated that Man-BSA modifies 
MAPK phosphorylation pattern in cells that had been 
stimulated by the parasite.  
In agreement with our results, MR was shown to 
participate in intracellular signalling leading to target 
gene expression [33, 48, 50-55]. Intracellular targeting 
is  mediated  by  a  tyrosine-based  motif  in  the  cyto-
plasmic tail [29]. It appears to require the assistance 
from other receptors in order to trigger any signalling 
cascade which is also consistent with the lack of sig-
nalling motifs in its cytoplasmic domain [56]. For in-
stance, Da Silva et al. [57] demonstrated that MR is a 
size  dependent  co-receptor  for  dectin-1  that  partici-
pates in the stimulation of TNF and inhibition of IL-10 
by small chitin, an abundant polysaccharide in nature. 
Additionally, Zhang et al. revealed the participation 
of  MR  in  NF-kB-mediated  gene  expression  in  re-
sponse to P. carinii in alveolar Mo [54]. In other work, 
the authors demonstrated that P. carinii induced MR 
and TLR2 interaction, which indicates that MR, after 
binding with the pathogen, might form a functional 
complex with TLR2 and facilitate signal transduction 
[51]. Consequently, our results demonstrated that MR 
could be involved in an additional mechanism during 
T. cruzi infection. We have observed MR expression 
increased in F4/80+ cells at 13 and 15 d.p.i. Therefore, 
Cz,  liberated  by  the  immune  defense  reaction,  may 
bind to MR providing a new environment that pro-
mote T. cruzi growth. 
On  the  other  hand,  MR  constitutively  recycles 
between the plasma membrane and the early endo-
somal compartment, even in the absence of any lig-
and.  At  the  steady  state  10-30%  of  the  receptor  is 
found  at  the  cell  surface  and  the  remaining  70%  is 
localized  intracellularly  [58].  In  our  system, 
MR-ligand  Man-BSA  as  well  as  T. cruzi  antigen  Cz 
favour MR recycling since acidic washes did not affect 
MR  behavior.  These  results  are  in  accordance  to 
Beharka et al. where they demonstrated that surfac-
tant protein A (SP-A) binds to MR on alveolar Mo and Int. J. Biol. Sci. 2011, 7 
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induces the activation of a signal transduction path-
way(s) leading to the increased in MR trafficking to 
the plasma membrane [55]. 
Thus, we postulate that during T. cruzi infection, 
Cz may contact with MR up-regulating arginase ac-
tivity and promoting the intracellular growth of par-
asites. Then, the parasite might enhance MR recycling.  
Furthermore, MR is expressed on F4/80+ peri-
toneal cells of T. cruzi infected mice at 13 and 15 days 
post infection coincident with parasitemia peak and 
arginase  up-regulation  [43]  indicating  that  MR  is 
up-regulated  during  T.  cruzi  infection.  Moreover, 
when we investigated the effect of MR blocking anti-
body  in  T. cruzi  infected  peritoneal  Mo,  we  clearly 
observed that arginase activity and intracellular par-
asite growth decreased. This work confirms that the 
ligation of MR on Mo might be an interesting evasion 
mechanism of the innate immune response used by T. 
cruzi to favor its installation in the host [59, 60]. Be-
sides, MR is important for pathogens entry into Mo 
[61, 62]. However, MR function in host defense is not 
yet clearly understood since it was demonstrated that 
MR  is  not  essential  for  host  defense  against  some 
parasite infections in MR-deficient mice [62, 63]. Even 
though, pathogen recognition through MR does not 
appear to enhance susceptibility of MR-deficient an-
imals to infection, the identification of parasite com-
ponents that bound to MR and induce arginase could 
represent a new field of investigations on Mo-T. cruzi 
interaction. 
On  the  other  hand,  the  molecular  mechanisms 
underlying  the  host-parasite  interactions  are  still 
waiting to be discovered. Taken together, this work 
contributes to the knowledge of new factors that in-
duce arginase, as well as the membrane receptors and 
signaling involved. It would make it possible to better 
identify  the  optimal  targets  to  inhibit  the  arginase 
pathway to control survival of T. cruzi in Mo. 
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